b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">29183746</PMID>\n        <DateCompleted>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>13</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2018</Year>\n            <Month>08</Month>\n            <Day>13</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1872-7573</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>213</Volume>\n                    <PubDate>\n                        <Year>2018</Year>\n                        <Month>Mar</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of ethnopharmacology</Title>\n                <ISOAbbreviation>J Ethnopharmacol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Assessment of the anti-snakebite properties of extracts of Aniba fragrans Ducke (Lauraceae) used in folk medicine as complementary treatment in cases of envenomation by Bothrops atrox.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>350-358</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0378-8741(17)33431-1</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jep.2017.11.027</ELocationID>\n            <Abstract>\n                <AbstractText Label="ETHNOPHARMACOLOGICAL RELEVANCE" NlmCategory="BACKGROUND">Extracts of leaves and bark of Aniba fragrans are used as tea (decoction) to treat snakebites in communities in the Brazilian Amazon. The aqueous extract of the leaves of A. fragrans has been proven to be effective against Bothrops venom, but only when pre-incubated with the venom. This study sought to assess the potential of different types of extract of this species to inhibit the biological activities of Bothrops atrox venom (BaV) when used the same way as in folk medicine. The main classes of secondary metabolites and the concentrations of phenolics in the extracts were also determined.</AbstractText>\n                <AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">Four types of extract of A. fragrans were prepared: aqueous extract of the leaf (AEL), aqueous extract of the bark (AEB), hydroalcoholic leaf extract (HLE) and extract of the residue from hydrodistillation of the leaf (ERHL). The phytochemical profiles of the aqueous extracts were determined using thin layer chromatography (TLC), and the concentrations of phenolics were measured by colorimetric assays. To investigate the potential of the extracts to inhibit the biological activities of BaV, in vitro tests for antiphospholipase and antifibrinolytic activities were performed. In vivo tests for antihemorrhagic and antidefibrinating activities were also carried out, as well as antimicrobial tests for activity against the main bacteria found in the oral cavity of snakes. Interaction between the extracts and the proteins in BaV was assessed by electrophoresis (SDS-PAGE) and Western blot (WB). The cytotoxicity of the extracts was assessed in a strain of MRC-5 human fibroblasts.</AbstractText>\n                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Terpenoids, flavonoids and condensed and hydrolysable tannins were detected in all the extracts. Metabolites such as coumarins, fatty acids and alkaloids were present in some extracts but not in others, indicating different phytochemical profiles. Phenolics content varied between extracts, and there were more tannins in AEB and HLE. In the in vitro tests, the extracts inhibited the phospholipase and fibrinolytic activities of BaV in the two ratios of venom to extract used. HLE exhibited effective antimicrobial action as it inhibited growth of 11 of the 15 bacteria investigated, including Morganella morganii, the main bacteria described in the oral cavity of snakes. The extracts failed to inhibit the defibrinating activity of BaV, and only the Bothrops antivenom had a significant effect (96.1%) on this activity. BaV-induced hemorrhage was completely inhibited by AEL and AEB when the pre-incubation (venom:extract) protocol was used. When administered orally, as in folk medicine, both AEB and AEL produced significant inhibition of hemorrhagic activity (maximum inhibition 46.5% and 39.2%, respectively). SDS-PAGE and WB of the extracts pre-incubated with BaV showed that the main proteins in the venom had been precipitated by the extracts. None of the four extracts showed cytotoxic effects in the tests carried out with a human fibroblast cell line.</AbstractText>\n                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">In addition to being effective in reducing hemorrhage when administered orally, the extracts displayed a high antimicrobial potential against microorganisms involved in secondary infections at the site of the snakebite. Once the extracts have been tested in accordance with the appropriate regulations, this species could potentially be used to produce a phytomedicine for complementary treatment of the secondary infections due to bacteria that aggravate the local signs and symptoms after snakebite envenomation.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2017 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>de Moura</LastName>\n                    <ForeName>Val\xc3\xa9ria Mour\xc3\xa3o</ForeName>\n                    <Initials>VM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Recursos Naturais da Amaz\xc3\xb4nia-PPGRNA, Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Santar\xc3\xa9m, PA, Brazil; Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil; Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Medicina Tropical -PPGMT, Universidade do Estado do Amazonas-UEA, Funda\xc3\xa7\xc3\xa3o de Medicina Tropical Dr. Heitor Vieira Dourado-FMT/HVD, Manaus, AM, Brazil. Electronic address: mouraovm@yahoo.com.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>da Costa Guimar\xc3\xa3es</LastName>\n                    <ForeName>Noranathan</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil. Electronic address: norah.costa@hotmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Batista</LastName>\n                    <ForeName>Luana Travassos</ForeName>\n                    <Initials>LT</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil; Programa Multi-institucional de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Biotecnologia-PPGBIOTEC, Laborat\xc3\xb3rio de Imunoqu\xc3\xadmica, Departamento de Parasitologia, Instituto de Ci\xc3\xaancias Biol\xc3\xb3gicas, Universidade Federal do Amazonas, UFAM, Manaus, AM, Brazil. Electronic address: luana_travassos@yahoo.com.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Freitas-de-Sousa</LastName>\n                    <ForeName>Luciana A</ForeName>\n                    <Initials>LA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Toxinologia, Laborat\xc3\xb3rio de Imunopatologia - Instituto Butantan, S\xc3\xa3o Paulo, SP, Brazil. Electronic address: Luciana.sousa@butantan.gov.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>de Sousa Martins</LastName>\n                    <ForeName>Joanderson</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil. Electronic address: donto_2005@hotmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>de Souza</LastName>\n                    <ForeName>Maria Carolina Scheffer</ForeName>\n                    <Initials>MCS</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa Multi-institucional de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Biotecnologia-PPGBIOTEC, Laborat\xc3\xb3rio de Imunoqu\xc3\xadmica, Departamento de Parasitologia, Instituto de Ci\xc3\xaancias Biol\xc3\xb3gicas, Universidade Federal do Amazonas, UFAM, Manaus, AM, Brazil. Electronic address: mcarol.biotec@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Oliveira de Almeida</LastName>\n                    <ForeName>Patr\xc3\xadcia D</ForeName>\n                    <Initials>PD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Laborat\xc3\xb3rio de Atividade Biol\xc3\xb3gica - Biophar, Faculdade de Ci\xc3\xaancias Farmac\xc3\xaauticas, Universidade Federal do Amazonas, AM, Brazil. Electronic address: patt_danielle@hotmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Monteiro</LastName>\n                    <ForeName>Wuelton Marcelo</ForeName>\n                    <Initials>WM</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Medicina Tropical -PPGMT, Universidade do Estado do Amazonas-UEA, Funda\xc3\xa7\xc3\xa3o de Medicina Tropical Dr. Heitor Vieira Dourado-FMT/HVD, Manaus, AM, Brazil. Electronic address: wueltonmm@gmail.com.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>de Oliveira</LastName>\n                    <ForeName>Ricardo Bezerra</ForeName>\n                    <Initials>RB</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Recursos Naturais da Amaz\xc3\xb4nia-PPGRNA, Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Santar\xc3\xa9m, PA, Brazil; Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil. Electronic address: rbo@ufopa.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Dos-Santos</LastName>\n                    <ForeName>Maria Cristina</ForeName>\n                    <Initials>MC</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa Multi-institucional de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Biotecnologia-PPGBIOTEC, Laborat\xc3\xb3rio de Imunoqu\xc3\xadmica, Departamento de Parasitologia, Instituto de Ci\xc3\xaancias Biol\xc3\xb3gicas, Universidade Federal do Amazonas, UFAM, Manaus, AM, Brazil. Electronic address: mcsantos1957@yahoo.com.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Mour\xc3\xa3o</LastName>\n                    <ForeName>Rosa Helena Veras</ForeName>\n                    <Initials>RHV</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programa de P\xc3\xb3s-gradua\xc3\xa7\xc3\xa3o em Recursos Naturais da Amaz\xc3\xb4nia-PPGRNA, Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Santar\xc3\xa9m, PA, Brazil; Universidade Federal do Oeste do Par\xc3\xa1- UFOPA, Laborat\xc3\xb3rio de Bioprospec\xc3\xa7\xc3\xa3o e Biologia Experimental -LabBBEx, Santar\xc3\xa9m, PA, Brazil. Electronic address: mouraorhv@yahoo.com.br.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>26</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Ireland</Country>\n            <MedlineTA>J Ethnopharmacol</MedlineTA>\n            <NlmUniqueID>7903310</NlmUniqueID>\n            <ISSNLinking>0378-8741</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000890">Anti-Infective Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000933">Antifibrinolytic Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000997">Antivenins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D003435">Crotalid Venoms</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D006490">Hemostatics</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010636">Phenols</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010936">Plant Extracts</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>9001-31-4</RegistryNumber>\n                <NameOfSubstance UI="D005337">Fibrin</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.1.-</RegistryNumber>\n                <NameOfSubstance UI="D010740">Phospholipases</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000890" MajorTopicYN="N">Anti-Infective Agents</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000933" MajorTopicYN="N">Antifibrinolytic Agents</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000997" MajorTopicYN="N">Antivenins</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017837" MajorTopicYN="Y">Bothrops</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002470" MajorTopicYN="N">Cell Survival</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D003435" MajorTopicYN="N">Crotalid Venoms</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005337" MajorTopicYN="N">Fibrin</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006490" MajorTopicYN="N">Hemostatics</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName>\n                <QualifierName UI="Q000633" MajorTopicYN="N">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010636" MajorTopicYN="N">Phenols</DescriptorName>\n                <QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010740" MajorTopicYN="N">Phospholipases</DescriptorName>\n                <QualifierName UI="Q000037" MajorTopicYN="N">antagonists &amp; inhibitors</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D024301" MajorTopicYN="N">Plant Bark</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010936" MajorTopicYN="N">Plant Extracts</DescriptorName>\n                <QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>\n                <QualifierName UI="Q000633" MajorTopicYN="Y">toxicity</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D018515" MajorTopicYN="N">Plant Leaves</DescriptorName>\n                <QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D012909" MajorTopicYN="N">Snake Bites</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">Aniba fragrans</Keyword>\n            <Keyword MajorTopicYN="N">Anti-snakebite properties</Keyword>\n            <Keyword MajorTopicYN="N">Antimicrobial properties</Keyword>\n            <Keyword MajorTopicYN="N">Bothrops atrox</Keyword>\n            <Keyword MajorTopicYN="N">Traditional knowledge</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2017</Year>\n                <Month>09</Month>\n                <Day>18</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>17</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>22</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2017</Year>\n                <Month>12</Month>\n                <Day>1</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2018</Year>\n                <Month>8</Month>\n                <Day>14</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2017</Year>\n                <Month>11</Month>\n                <Day>30</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">29183746</ArticleId>\n            <ArticleId IdType="pii">S0378-8741(17)33431-1</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jep.2017.11.027</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'